Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Completed · Phase 1/Phase 2

Conditions studied: Liver Cancer, Hepatocellular Carcinoma

In brief

This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.

Key facts

Study ID

NCT00614913

Run by

Loma Linda University

People needed

76

Starts

1998-05-01

Expected to finish

2009-02-01

Last updated by the study team

2012-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of hepatocellular carcinoma
• Adult patients aged 18 years old and above
• Ability to give informed consent for study
• Compensated liver disease

You may not qualify if…

• Pediatric patients (aged less than 18 years old)
• Decompensated or advanced liver disease
• Poorly controlled ascites
• Variceal hemorrhage within the previous 30 days
• Recurrent hepatic encephalopathy
• Cirrhosis with CTP* score >10
• Active alcohol or drug abuse
• Anticipated survival of less than 30 days
• Advanced co-morbid medical illnesses
• Karnofsky Performance Score <60
• Tumor characteristics:
• Any tumor that can not be safely and effectively irradiated due to inability to deliver target treatment dose to required treatment volume or due to prohibitively high risk of anticipated toxicities to normal liver or nearby bowel, stomach, kidney or spinal cord.

Where it is running

• Loma Linda University Medical Center / James M. Slater Proton Treatment Center — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.